the aid library

LIST OPTIONS

Filter

6043

Perfil de País Bolivia - Resistencia Antimicrobiana

SAIDI (South American Infections Diseases Initiative) (2009) C2

La publicación que aquí presentamos busca mostrar los resultados de la iniciativa SAIDI en los países intervenidos, para ello se entrega un perfil que muestra el panorama de la situación de la resistencia antimicrobiana, pre y post iniciativa, así como información clave de los ...ores que trabajan en el tema. Está dirigida al personal técnico y a los tomadores de decisiones, que abordan desde sus distintas perspectivas el tema del uso de antibióticos y la resistencia a los antimicrobianos. more

Download (116)

View PDF (147)

Uso Racional de Medicamentos: Una Tarea de Todos Contenidos e Información del Uso Racional de Medicamentos para el personal técnico de salud

Ministerio de Salud Chile (2010) C2

El Ministerio de Salud de Chile, atendida la relevancia de los medicamentos dentro del sistema de salud público y privado, ha planteado en la Política Nacional de Medicamentos (Res. Ex. MINSAL Nº 512/2004) los lineamientos y directrices bajo las cuales se deberá desarrollar la ...ividad nacional en materia farmacéutica y dentro de éstos de encuentran las líneas de acción respecto de la Racionalidad en el Uso de Medicamentos, que estructuran una serie de actividades destinadas a lograr un uso racional de los mismos. more

Download (152)

View PDF (120)

Guia para las Buenas Prácticas de Prescripción Metodología para la Prescripción Racional de Medicamentos

Ministerio de Salud Chile (2010) C2

El documento que se presenta, aborda la Prescripción desde su esencia como un proceso racional y metódico, que basándose en los antecedentes diagnósticos pertinentes, permite la mejor elección posible de los medicamentos requeridos por el paciente. Asimismo, se han incorporado algunos anteceden... more

Uso Racional de Medicamentos: Una Tarea de Todos

Ministerio de Salud Chile (2010) C2

El documento que se presenta, aborda el Uso Racional de Medicamento, así como aquellos conceptos que son requeridos para su apropiado establecimiento; y está destinado al personal técnico de salud, quienes realizan una importante labor complementando la acción de salud y en muchas ocasiones culm... more

External Link

The Oxford Statement on Medicine Quality and Public Health

Nuffield Dept. of Medicine Centre for Tropical Medicine and Global Health (2018) CC

In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement... more

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but mo...st have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidence map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

External Link

GPHF-Minilab: Manuals
recommended

Global Pharma Health Fund E.V. (2020) C1

GPHF Minilab manuals on basic dye and thin layer chromatographic testing. The newest version of the manual (Volume I + II) from 2008 is available in three languages: English, French, Spanish. Combining the main manual with the supplements issued each year between 2010 and 2015, label claims on drug... more

Download (483)

View PDF (754)

Updating national essential medicine lists: a step-by-step advocacy guide

MSH Management Sciences for Health (MSH) (2016) C1

This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the ...ors, timeline, and process may vary from country to country, this guide presents the broad steps involved in revising an EML for any health commodity. Additional resources and a glossary are included to provide supplemental information and to clarify key terms. more

Download (758)

View PDF (886)

Medical Product Alert N° 4/2016: Falsified Quinine Sulphate circulating in West and Central Africa

World Health Organization (2016) C_WHO

This Medical Product Alert relates to the recent circulation of two confirmed falsified versions of Quinine Sulphate circulating in Cameroon and the Democratic Republic of the Congo, containing zero active pharmaceutical ingredient

Download (623)

View PDF (966)

Alerte Produit Médical N° 4/2016 Quinine Sulfate falsifiée circulant en Afrique de l’Ouest et en Afrique Centrale

Organisation Mondiale de la Santé (OMS) (2016) C_WHO

Cette Alerte fait référence à la circulation au Cameroun et en République Démocratique du Congo, de deux versions falsifiées confirmées de Quinine Sulfate, qui ne contiennent aucun principe actif.

2021 Antibacterial agents in clinical and preclinical development: an overview and analysis

World Health Organization WHO (2022) C_WHO

This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in... more

Déclaration sur l’utilisation de l’ivermectine pour la COVID-19

African Union; Africa CDC Centres for Disease Control and Prevention (2021) C1

L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la prévention et le traitement ... more

Download (125)

View PDF (278)

Profilaxis Post Exposición para el VIH en personas adultas Recomendaciones abreviadas para el equipo de salud

Ministerio de Salud Argentina (2019) C2

La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu... more

External Link

Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures

World Health Organization WHO (2016) C_WHO

Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th... more

Download (242)

View PDF (319)

NATIONAL GUIDELINES FOR COMPREHENSIVE CARE OF PEOPLE LIVING WITH HIV IN RWANDA

Ministry of Health, Rwanda (2011) C2

This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal... more